Completed OBSERVATIONAL NCT04687046

A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence

A Real-World Evidence Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults

Sponsor: Allergan

Updated 7 times since 2021 Last updated: Feb 16, 2023 Started: Feb 4, 2021 Primary completion: Feb 28, 2022 Completion: Feb 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04687046, this observational or N/A phase trial focuses on Chin Retrusion and remains completed. Sponsored by Allergan, it has been updated 7 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2023 — Jul 2024 [monthly]

Completed
Apr 2022 — Mar 2023 [monthly]

Completed

Status: Recruiting → Completed
Dec 2021 — Apr 2022 [monthly]

Recruiting

▶ Show 2 earlier versions

Oct 2021 — Dec 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allergan

Data source: Allergan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Qionghai, China